Both in Pharmaceuticals
Mineralys Therapeutics vs Korsana Biosciences
Over the past year MLYS returned −44.9% and KRSA returned −0.8%; their daily moves had a correlation of 0.05.
MLYS −44.9% KRSA −0.8%Growth of $1, one year, split-adjusted
| Metric | MLYS | KRSA |
|---|---|---|
| Price | $15.55 | $31.66 |
| Market cap | $1.37B | $1.44B |
| Today | −14.47% | +5.04% |
| 1 month | −34.2% | +3.8% |
| 6 months | −47.6% | — |
| Year to date | −57.2% | — |
| 1 year | −62.2% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $563.8M | — |
| Dividend yield | — | — |
| Volatility (60d) | 72.0% | — |
| Short % of float | 11.6% | 1.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).